APOLLO ENDOSURGERY, INC. APEN Income Statement

Apollo endosurgery, inc. (APEN)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues
48,220	50,713	53,906	56,788	58,322	60,854	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of sales
0	-	0	0	0	-	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Grant and royalty revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	228	342	529	631	649	1,222	1,375	1,484	1,513	1,166	1,032	989	1,165	1,054	1,172	1,617	1,980	1,750	0	0	0
Research and development revenue under collaborative agreements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,282	3,217	3,615	4,448	5,820	6,686	7,218	6,502	5,351	4,566	4,009	5,698	7,625	8,097	8,193	7,768	5,874	0	0	-	0
Revenues
-	-	-	-	-	-	-	-	-	-	-	-	62,890	64,650	115,601	99,876	83,283	67,790	2,511	3,560	4,144	5,080	6,469	7,909	8,594	7,986	6,865	5,732	5,042	6,688	8,791	9,151	9,366	9,386	6,866	6,093	0	0	0
Cost of sales
-	-	-	-	-	-	-	-	-	-	-	-	25,442	25,255	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross margin
24,071	25,675	26,922	29,230	31,245	33,194	35,418	38,209	39,501	39,732	39,773	39,774	37,448	39,395	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating expenses:
Sales and marketing
27,363	28,730	29,748	30,597	31,283	32,831	33,156	33,790	33,881	32,910	32,739	31,593	31,486	31,533	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
13,210	13,588	14,066	13,928	13,834	13,436	13,018	12,855	12,854	13,722	15,110	16,094	15,177	13,625	17,209	14,225	12,996	11,412	4,480	4,671	4,652	4,758	4,434	4,361	4,387	4,234	4,354	4,449	4,213	4,091	3,874	3,578	3,499	3,370	3,029	3,230	0	0	0
Research and development
9,103	10,384	11,140	12,683	13,148	12,176	11,160	9,667	8,798	8,299	9,003	8,607	8,108	7,805	7,677	7,325	8,456	9,558	13,360	15,560	17,219	18,126	15,434	15,157	13,421	11,343	9,600	7,948	6,641	8,158	11,048	11,052	10,898	9,726	6,169	7,220	0	0	0
Amortization of intangible assets
2,038	2,095	3,254	4,551	5,825	7,074	7,207	7,203	7,228	7,240	7,238	7,234	7,228	7,193	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Settlement gain
0	5,609	5,609	5,609	5,609	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
51,714	49,188	60,369	63,920	66,251	73,287	64,541	63,515	62,761	62,171	64,090	63,528	61,999	60,156	96,905	84,938	74,545	63,963	17,840	20,232	21,871	22,885	19,868	19,519	17,809	15,578	13,955	12,397	10,855	12,249	14,923	14,630	14,397	13,096	9,198	10,451	0	0	0
Loss from operations
-27,643	-23,513	-33,447	-34,690	-35,006	-40,093	-29,123	-25,306	-23,260	-22,439	-24,317	-23,754	-24,551	-20,761	-21,170	-19,674	-16,681	-16,683	-15,329	-16,671	-17,726	-17,805	-13,399	-11,609	-9,215	-7,591	-7,090	-6,664	-5,812	-5,561	-6,131	-5,479	-5,031	-3,710	-2,331	-4,357	0	0	0
Other expenses:
Interest expense, net
4,337	4,052	3,932	3,712	4,062	4,063	3,948	3,960	3,987	4,508	14,827	15,347	16,823	18,168	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other expense (income), net
-2,637	408	-1,010	-1,132	-1,205	-1,440	0	0	0	-	0	0	0	-	0	0	0	-	-	0	-	-	-	0	-	26	-20	-68	-35	-90	-39	40	10	-4	-68	-88	0	0	0
Net loss before income taxes
-34,617	-27,157	-38,389	-39,534	-40,273	-45,596	-34,491	-29,615	-26,897	-26,988	-39,337	-40,419	-43,042	-40,780	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax expense
267	275	200	156	184	191	258	277	312	304	352	301	338	387	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-34,884	-27,432	-38,589	-39,690	-40,457	-45,787	-34,749	-29,892	-27,209	-27,292	-39,689	-40,720	-43,380	-41,167	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Current dividends on convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,800	650	600	1,000	300	1,350	1,200	2,900	1,100	2,600	4,200	600	300	-100	0	0	0
Total other income (expense), net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,026	279	1,281	1,164	2,809	1,060	2,640	4,210	595	231	-188	0	0	0
Net loss attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-57,080	-50,978	-41,871	-36,382	-14,029	-14,971	-16,026	-16,555	-11,599	-10,959	-8,615	-6,564	-6,811	-5,383	-4,648	-2,752	-5,070	-2,839	-820	-3,114	-2,100	0	0	0	-
Other comprehensive income (loss):
Foreign currency translation
1,829	-871	418	740	204	706	661	-64	-204	324	10	643	1,214	1,463	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive loss
-33,055	-28,303	-38,171	-38,950	-40,253	-45,081	-34,088	-29,956	-27,413	-26,968	-39,679	-40,077	-42,166	-39,704	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share, basic and diluted (USD per share)
-0.49	-0.34	-0.40	-0.40	-0.13	-0.86	-0.45	-0.53	-0.47	-0.28	-0.32	-0.64	-0.77	-20.10	-24.85	-35.30	-25.44	-148.90	-1.06	-1.80	-0.14	-0.34	-0.20	-0.23	-0.23	-0.11	-0.19	-0.10	-0.09	-	-0.10	-0.06	-	-	-	-	-	-	-
Shares used in computing net loss per share, basic and diluted (shares)
21,117	20,933	21,401	21,926	21,907	21,969	21,885	18,005	17,299	17,384	15,481	10,702	10,694	564	335	333	324	-22,339	2,100	1,482	19,715	19,689	16,155	15,865	14,511	13,504	13,428	13,419	13,401	-	11,004	10,980	-	-	-	-	-	-	-
Basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.07	-	0.13	0.02	-0.03	-0.05	-0.02
Diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.07	-	0.12	0.02	-0.03	-0.05	-0.02
Basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,558	-	9,009	62,943	62,677	54,945	54,730
Diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,748	-	9,266	65,584	62,677	54,945	54,730